ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,120 filers reported holding ASTRAZENECA PLC in Q4 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $927,137 | +13.0% | 11,859 | -1.4% | 0.10% | +11.7% |
| Q1 2024 | $820,690 | +2.5% | 12,023 | +1.1% | 0.09% | -2.1% |
| Q4 2023 | $800,601 | +1.3% | 11,896 | +1.5% | 0.10% | -2.0% |
| Q3 2023 | $790,500 | -8.4% | 11,725 | -3.7% | 0.10% | -2.0% |
| Q2 2023 | $862,740 | +2.8% | 12,177 | +0.4% | 0.10% | -4.8% |
| Q1 2023 | $839,534 | +5.3% | 12,132 | +3.7% | 0.10% | +1.0% |
| Q4 2022 | $797,042 | +41.8% | 11,704 | +14.4% | 0.10% | +42.5% |
| Q3 2022 | $562,000 | -14.2% | 10,235 | +4.8% | 0.07% | -11.0% |
| Q2 2022 | $655,000 | +22.2% | 9,769 | +22.2% | 0.08% | +34.4% |
| Q1 2022 | $536,000 | +94.9% | 7,993 | +70.0% | 0.06% | +96.8% |
| Q4 2021 | $275,000 | -33.3% | 4,701 | -43.0% | 0.03% | +93.8% |
| Q1 2021 | $412,000 | -47.6% | 8,251 | -47.4% | 0.02% | -52.9% |
| Q4 2020 | $787,000 | -14.4% | 15,684 | -5.9% | 0.03% | -26.1% |
| Q3 2020 | $919,000 | +40.1% | 16,672 | +34.5% | 0.05% | +35.3% |
| Q2 2020 | $656,000 | +20.4% | 12,395 | +1.2% | 0.03% | +13.3% |
| Q1 2020 | $545,000 | +33.3% | 12,242 | +49.5% | 0.03% | +50.0% |
| Q4 2019 | $409,000 | +20.3% | 8,186 | +9.0% | 0.02% | +11.1% |
| Q3 2019 | $340,000 | +14.5% | 7,510 | +3.7% | 0.02% | +12.5% |
| Q2 2019 | $297,000 | -3.9% | 7,245 | +0.8% | 0.02% | -11.1% |
| Q1 2019 | $309,000 | -54.2% | 7,186 | -59.8% | 0.02% | -60.0% |
| Q4 2018 | $675,000 | -11.5% | 17,866 | -7.0% | 0.04% | 0.0% |
| Q3 2018 | $763,000 | -30.3% | 19,203 | -38.8% | 0.04% | -36.6% |
| Q2 2018 | $1,095,000 | -18.7% | 31,385 | -18.1% | 0.07% | -21.1% |
| Q1 2018 | $1,347,000 | +5.7% | 38,333 | +2.6% | 0.09% | +9.8% |
| Q4 2017 | $1,274,000 | +26.8% | 37,355 | +24.4% | 0.08% | +22.4% |
| Q3 2017 | $1,005,000 | +36.5% | 30,021 | +39.2% | 0.07% | +28.8% |
| Q2 2017 | $736,000 | +27.8% | 21,568 | +17.2% | 0.05% | +15.6% |
| Q1 2017 | $576,000 | +90.7% | 18,396 | +66.5% | 0.04% | +73.1% |
| Q4 2016 | $302,000 | +16.2% | 11,050 | +40.4% | 0.03% | -3.7% |
| Q3 2016 | $260,000 | – | 7,869 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
| Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
| Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
| ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
| Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
| Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
| Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
| Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
| Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |